Press Releases
President Signs Bill that Advances Lupus Research and Care

May 5, 2017. NEW YORK, NY. A bipartisan spending bill for Fiscal 2017 that includes key provisions the Lupus Research Alliance and lupus advocates across the country have fought for was signed into law today. The bill establishes for the first time an annual $5 million lupus medical research program at the Department of Defense […] READ MORE

2017 Lupus Handbag Luncheon Supports Science With Style

NEW YORK, NY – April 4, 2017. Nearly 300 prominent women and men from New York’s fashion, society, entertainment, publishing, philanthropic and lupus communities came together today to raise funds for lupus research. The 8th annual Lupus Handbag Luncheon & Silent Auction was the first hosted by the Lupus Research Alliance, formed by the recent merger […] READ MORE

Lupus Research Alliance Inaugural Gala Honors Founding Board & Pfizer Inc

NEW YORK, NY – The newly merged Lupus Research Alliance celebrated its debut at the Inaugural Gala, uniting the three world leaders in lupus research as the driving force for better treatments and a cure. In just one night, the country’s largest lupus fundraising event raised over $2.5 million – with every dollar going directly to support lupus […] READ MORE

Lupus Research Alliance Launches Clinical Trial Network

NEW YORK, NY — The Lupus Research Alliance launched a bold initiative, the Lupus Clinical Investigators Network (LuCIN) to accelerate the identification and development of new therapies to treat lupus. Comprised of leading lupus experts at 58 academic research centers throughout North America, LuCIN provides a coordinated framework to test potential new treatments quickly and cost-effectively while upholding the highest […] READ MORE

Lupus Research Alliance Announces Published Data Showing Effective Approach to Drug Repositioning

Crowd-sourcing, Literature Review and Big Data Analysis Identify Promising Lupus Treatments NEW YORK, NY –- New results published in the professional journal Lupus demonstrate the effectiveness of an innovative system developed to identify promising treatments for lupus among existing drugs approved for use in other diseases. Funded by the Lupus Research Alliance and the John and Marcia […] READ MORE

Lupus Research Alliance Welcomes Voclosporin Trial Results

First Promising Phase II Data in Lupus Nephritis NEW YORK, NY — The Lupus Research Alliance congratulates Aurinia Pharmaceuticals on achieving the first positive Phase II study of a greatly needed potential treatment for lupus nephritis. Up to 60% of people with lupus develop lupus nephritis, a devastating complication that can cause kidney failure and […] READ MORE

Learn and connect with our community!